Test 5 Flashcards
Antihistamine receptors, side effects, patient teaching
H1 receptor blocker
SE: Drowsiness, dry mouth, urinary retention, hypotension, tachycardia, constipation, often stimulatory in children
Pt Teaching: Avoid alcohol and opioids, fall risk in older adults, take before s/s of allergies,not for children because of idiosyncratic effects
guaifenesin (Mucinex) therapeutic indication, mechanism of action
I: dry non-productive cough
MOA: Increase expelling of bronchial secretions by thinning Mucus
Inhalation therapy patient teaching, rationale for using this route
pt: ○ Prime spray
○ Clear nasal passage
○ Insert the tip aiming high in the nasal cavity and toward the back of head
○ Close the opposite nostril, breathe in slowly and spray
○ Spit out any excess liquid.
Inhalation offers rapid and efficient bronchodilation directly to the site of action in the lungs, dramatically decreasing the onset of action *can also use lower dose
The enormous surface area of the bronchioles and alveoli and the rich blood supply to these areas results in an almost instantaneous onset of action with little systemic toxicity
oxymetazoline (Afrin) teaching, complications
pt: *if coronary artery disease-get doc approval, don’t use for longer than 3-5 days! to avoid rebound congestion. if using a corticosteroid use sympathomimetic first then wait a minute for cortico.
C: htn, rebound congestion (hypersecretion of mucous/swelling), dries mucous membranes.
Oral and intranasal route differences in general
Most oral decongestants are sympathomimetics (adrenergic drugs) nnm
○ Many combination drugs, but single dose is safer
○ Oral have a longer onset of action
○ Intranasal drugs are deliverd via sprays directly to their site of action which offers
rapid and efficient relief.
○ Oral more likely for systemic effects
Pseudoephedrine (Sudafed) patient teaching
pt: monitor hr-tachycardia, bp-htn, palpitation, dysthymias-cardiac disease pts
tracked betweeen pharmacies
possible s/e hypertension, cns stim (anxiety, insomnia, urinary retention-if pre existing issues. )
Asthma medication treatment goals
*asthma drugs
moa
where it works (mucus membrane, bronchioles, etc.)
route of administration
Goal: Terminate acute bronchospasms and to reduce the frequency of asthma attacks
Dry powder inhalation (DPI) mechanism
○ Offers rapid and efficient bronchodilation directly to the site of action in the lungs,
dramatically decreasing the onset of action
○ Large surface area and rich blood supply of bronchioles and alveoli mean almost
instantaneous onset of action with little systemic toxicity
○ Activated by inhalation
○ Have longer duration of action
○ Easier to use- less complex for pts
albuterol (Proventil) indication, side effects, mechanism of action, patient teaching
I: acute bronchospasm - most effective
SE: tachycardia, dysrhythmias, tremors, anxiety, headache, throat irritation, hyperglycemia
MOA: activate B2 receptors which causes bronchodilation, Stimulates SNS, Widens airways
Pt teaching: use correct technique, use at first sign of asthma attack, label as rescue inhaler
Glucocorticoid inhalation side effects
Hoarseness, dry mouth, thrush, long term use: cataracts
Leukotriene modifiers [zafirlukast (Accolate)] indication
I: Prophylaxis of persistent chronic asthma. Decrease inflammation in lungs
ipratropium (Atrovent) contraindication, patient teaching
C: *no use in children under 12
propellent is may of soy lecithin (no use if soy or peanut allergy),
Assess for history of narrow-angleglaucoma, benign prostatic hyperplasia, renal disorders, urinary bladder neck obstruction
◦ Contraindicated in clients with history of these and in elderly
Pt: keep away from eyes, s/e *few systemic. Headache, bitter taste (rinse), dry cough, dry mouth, irritate mucous membranes in throat (airway irritation)
Note: more effective when used in combination with beta agonists, specifically LABA’S ) *results in longer duration of action.
GERD treatment goal
G: reduce gastric acid secretion
H2-receptor antagonist indication, mechanism or action
I: peptic ulcer disease and GERD
MOA: acid reduction via Decrease of acid secretion from parietal cells
ranitidine (Zantac) patient teaching
pt: ○ H2 receptor antagonist
○ Don’t take at same time as PPIs and antacids
○ Take c meal or at bedtime, best c food